A fine punt indeed27 Aug 2006 09:32
This looks to be a fine company and a share price crash of this nature is entirely down to a single trade in a very thin market.
Up to the 21st August there had been just 4 (yes four) trades in these shares in the prior 3 weeks. On the 21st August, as you point out, a shareholder dumped 150000 shares at 30p (prior price was 108-113p) and there were 25 further trades that day, mostly buys. Since then we've had daily trades of between 10 and 50+. The market appears to have finally noticed this company following the price fall.
AKI has recently signed distribution agreements for its products in Switzerland, Italy, Austria and (in July) Australia. The latter agreement would appear to have the greatest potential since it also covers export of products from Australia into South East Asia.
What particularly interests me is this 'strategic alliance' with Australian Biotechnologies Pty Ltd. This company manufactures and engineers innovative human tissue-based products to repair and promote natural healing of human bone and other tissues. I have some limited knowledge in this area, and the range of products worldwide is very small but the potential market quite vast.
I disagree that their market is mature, the technology is moving along rapidly and the regeneration idea is much newer (typically artificial disc replacement has been used). What we appear to have here is a successful German company, expanding rapidly and with great potential, whos share price has suffered fro